David Haylock
Chief Scientific Officer VivaZome
David Haylock is a stem cell biologist with a passion for translating basic research into new technologies and products to advance healthcare. He has led the R&D program at VivaZome Therapeutics since 2018 where he has established a scalable EV manufacturing technology supported by a suite of analytics and fit-for-purpose potency assays enabling progression toward clinical-grade EV production.
Seminars
Thursday 24th September 2026
Reviewing the Challenges & Opportunities Associated With Manufacturing of Anti-Inflammatory Exosome Products to Overcome Scale Up Challenges
11:30 am
- Reviewing the cost of goods consideration in EV product manufacture
- Issues to be addressed in scaling up of exosome manufacture
- Ensuring the quality and function of exosome products, including the selection and design of in vivo animal models
